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This monograph forms part of a series of disease monographs commissioned by the 
International Development Research Centre over the period Nov 2015 to April 2016 to 
inform funding priorities for the Livestock Vaccine Innovation Fund (LVIF). The LVIF is a 
seven-and-a-half year, CA$57 million partnership between the Bill & Melinda Gates 
Foundation, Global Affairs Canada and Canada’s International Development Research 
Centre. It focuses on those animal diseases posing the greatest risk to poor livestock 
keepers in Sub-Saharan Africa, South and Southeast Asia, targeting transboundary 
diseases to achieve lasting regional impact. 
 
The content presented here is as submitted by the consultant(s) involved and has been 
edited for appearance only. The views, information, or opinions expressed in this 
monograph are solely those of the individual consultant(s) involved and do not 
necessarily represent those of the Bill & Melinda Gates Foundation, Global Affairs Canada 
and International Development Research Centre, or any of their employees. Sections of 
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AAT  Animal African Trypanosomosis 
AT  African Trypanosomosis 
AU  African Union 
AU-IBAR African Union Inter-African Bureau for Animal Resources 
AU-PATTEC African Union - Pan African Tsetse and Trypanosomiasis Eradication Campaign 
BBRSC  Biotechnology and Biological Sciences Research Council 
BMGF  Bill and Melinda Gates Foundation 
CVO  Chief Veterinary Officer 
DALY  Disability-adjusted life year  
DIVA  Differentiate infected from vaccinated animals 
DVS  Director Veterinary Services 
ELISA  Enzyme-linked immunosorbent assay 
FAO   Food and Agriculture Organization of the United Nations 
IAEA  International Atomic Energy Agency of the United Nations 
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PCR  Polymerase chain reaction 
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Tc  Trypanosoma congolense 
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Etiology and relevance 
Tsetse-transmitted Trypanosomosis (as opposed to non-testse transmitted Trypanosomosis, generally caused by 
T. vivax in Latin America, and Trypanosoma evansi) is an infectious disease unique to Africa caused by T. 
congolense, T. vivax, or T. brucei brucei, or simultaneous infection with one or more of these trypanosomes. The 
disease affects both people [Human African Trypanosomosis (HAT) or sleeping sickness] and animals [Animal 
African Trypanosomosis (AAT) or Nagana] and occurs in 37 sub-Saharan countries covering more than 9 million 
km2, an area which corresponds approximately to one-third of the Africa's total land area. The infection 
threatens an estimated 60 million people and about 50 million head of cattle. It can also cause serious losses in 
pigs, camels, goats, and sheep.  
In East Africa, T. congolense is considered to be the single most important cause of AAT in cattle, while it is also 
of major importance in West Africa. Although T. vivax is considered to be less pathogenic for cattle than T. 
congolense, it is nevertheless the most important cause of AAT in West African cattle. T. vivax readily persists in 
areas free of tsetse flies (for example, in Central and South America and in the Caribbean), where it is 
transmitted mechanically by biting flies or contaminated needles, syringes, and surgical instruments.  
Several types of T. congolense can be distinguished by molecular biology; the most common and pathogenic one 
in cattle is the type “savannah” (large variation in pathogenicity within the savannah subgroup), the other ones 
(type “forest” and “Kilifi” or Kenya coast) are less pathogenic and have different host affinity. 
 
Epidemiology 
While Cattle, sheep, goats, pigs, horses, camels, dogs, cats, and monkeys are susceptible to AAT and may suffer 
syndromes ranging from subclinical mild or chronic infection to acute fatal disease, more than 30 species of wild 
animals can be infected with pathogenic trypanosomes, and many of these remain carriers of the organisms. 
Ruminants are widely known to be active reservoirs of the trypanosomes. Wild Equidae, lions, leopards, and wild 
pigs are all susceptible and can also serve as carriers of trypanosomes. 
AAT occurs where the tsetse fly vector exists in Africa, between latitude 15°N and 29°S, although due to its 
ability to be mechanically transmitted, T. vivax has spread beyond these limits. 
Of the 32 species of tsetse fly, Glossina spp; known to be competent to carry the 3 AAT agents, 3 species are the 
major vectors: Glossina morsitans, which favors the open woodland of the savanna, G. palpalis, which prefers 
the shaded habitat immediately adjacent to rivers and lakes; and G. fusca, which favors the high, dense forest 
areas. 
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Transmission of trypanosomes is essentially cyclical: they are transmitted through the bite of an infected tsetse 
fly. Tsetse flies get the infection when feeding on an infected animal; after implementation of the parasitic cycle 
in the fly (15–21 days) it becomes infective and may remain infective for the rest of its life. 
Mechanical transmission also occurs with T. vivax, while other forms, such as vertical transmission can occur 
intra-utero and during partum. 
A number of cattle breeds in West Africa have developed Trypanotolerance, or the ability to harbour natural 
trypanosome infections without developing severe disease symptoms. The most known of these breeds is the 
Bos taurus N’Dama, but also other similar West African taurine breeds. There are also trypanotolerant zebu 
breeds in East Africa. 
Clinical signs of AAT are not always clear cut. In cattle the disease is usually chronic – some animals may slowly 
recover but usually relapse when stressed. The most important clinical sign is non-regenerative anaemia, and 
the most common reason animals are unable to function normally. When tsetse challenge is high, morbidity is 
usually also high. All three species of trypanosomes will eventually cause death in their hosts unless treated. 
 
Economic impact 
Every year, AAT causes about 3 million deaths in cattle while approximately 35 million doses of trypanocidal 
drugs are administered. Nagana has a severe impact on agriculture in sub-Saharan Africa. The economic losses in 
cattle production alone are in the range of US$ 1.0 - 1.2 billion. A ponderated evaluation extrapolated for the 
total tsetse-infested lands values total losses, in terms of agricultural Gross Domestic Product, at US$ 4.75 billion 
per year 
African animal trypanosomosis (AAT) is a very important disease of domestic livestock in sub-Saharan Africa. 
According to the Food and Agriculture Organization of the United Nations (FAO), it is probably the only disease 
which has profoundly affected the settlement and economic development of a major part of a continent. 
 
Diagnostics 
Trypanosomiasis is generally suspected when an animal in an endemic area is anaemic and in poor condition. 
Confirmation depends on the demonstration of the organism in blood or lymph node smears. When parasitemia 
is low, smears of buffy coat (obtained by microhematocrit centrifugation) can be useful for demonstration of the 
parasites. Buffy coat samples are also used for haematocrit and could be also used for PCR. Serological methods 
exist for antibody, ELISA and Indirect fluorescent antibody test, while different antigen ELISAs have also been 
developed. 
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The control of trypanosomoses has not much changed over the last hundred years and still relies on (1) the 
control of the vector, (2) the use of trypanocidal and prophylactic drugs and (3) the use of trypanotolerant 
livestock. Another important element is the correct diagnosis of the disease. There is still no vaccine or 
immunisation method to date for AAT. 
Integrated control approaches are generally recommended and have been successfully applied in countries like 
Ethiopia. They should be encouraged and implemented in as many regions as possible.    
Several approaches have been applied and are still in application in different affected and endemic regions. 
These have included aerial and land spray of different types of insecticides targeting the tsetse flies. Sterile male 
techniques, which rely on the fact that females mate only once in a lifetime, have been promoted and used in a 
number of regions; but have been difficult to implement on all types of Glossina and are expensive. Other 
techniques with mixed results include traps and odour-baited targets impregnated with insecticides. 
Trypanocides: The main drugs used for AAT are isometamidium chloride (ISM) which has both curative and 
prophylactic effects and diminazene aceturate (DA) which has only curative properties. These drugs have been 
in use for more than half a century. Approximatly 35 million doses of trypanocides are administered every year 
in sub-Saharan Africa, with ISM, ethidium bromide and DA representing 40%, 26% and 33% respectively. Despite 
their high usage, the pharmaceutical industries have been unwilling to invest in research for developing new 
products, leaving farmers to rely on the existing drugs. Farmers currently have easy access to these trypanocides 
and this has resulted in rampant numbers of substandard and counterfeit drugs, misuse and under-dosage of 
the medications, actions which have been blamed for the emergence of trypanocidal drug resistance. To date, 
there are 17 countries in which trypanocidal drug resistance has been reported. 
No vaccine to AAT has been developed to date nor likely in the near future because of the ability of 
trypanosomes to rapidly change variable surface glycoproteins (VSG) in their coats to avoid an effective Immune 
response (antigenic variation). This also leads to establishment of prolonged infections with intermittent 
parasitaemias. There are estimated to be about 1,000 VSGs, in the trypanosomal coat, which switch genetically 
as antibodies are produced by the host. 
Alternative approaches have been researched by different group for vaccine development. The most extensively 
studied has been the concept of anti-disease vaccines, which were inspired by the fact that trypanotolerant 
cattle can harbour natural trypanosome infections without developing severe disease symptoms. It was then 
hypothesised that some parasite proteins or virulence factors played a role in the disease process and that an 
immune response to these factors may contribute to the mechanisms underlying trypanotolerance. Despite the 
evaluation of several of these factors, the most studied being the congopain, no conclusive and convincing 
vaccine could be developed. To date few other groups have been working on different approaches, including 
irradiated Trypanosoma.  
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The future of AAT vaccines and vaccination  
While the development of a vaccine for AAT seems far from reach, it is possible to control and sometimes 
eradicate the disease and the vector as it has been done in some regions. It has been shown that integrated 
control approaches are always more effective in controlling AAT. Supporting such approaches should be 
encouraged in order to improve the livelihood of livestock keepers leaving in endemic affected regions of Africa.  
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In sub-Saharan Africa, animal African Trypanosomosis (AAT) is considered one of the major constraints to 
livestock production and development, and one of the most important animal diseases - with more than 80 
million cattle exposed to infective tsetse fly bites (T. congolense, T. brucei brucei) or infective tsetse fly and biting 
fly bites (T. vivax) [5]. It is estimated to cause annual losses that run into billions of dollars. AAT currently causes 
direct annual losses of some US$ 1.5 billion and, overall, has the effect of limiting Africa’s agricultural income to 
some US$ 4.5 billion a year below its potential level [5][11]. 
There are two groups of Trypanosomosis that are generally recognised: the tse-tse transmitted and the non-
tseste transmitted Trypanosomosis.  Tsetse-transmitted trypanosomosis is a disease complex caused by several 
species of protozoan parasites of the genus Trypanosoma, mainly transmitted cyclically by the genus Glossina 
(tsetse flies), but also transmitted mechanically by several biting flies (tabanids, stomoxes, etc.) [20]. 
African trypanosomiasis is an infectious disease of humans and animals of similar aetiology and epidemiology. 
The causative agents of the disease are protozoan parasites of the genus Trypanosoma that live and multiply 
extracellularly in blood and tissue fluids of their mammalian hosts and are transmitted by the bite of infected 
tsetse flies (Glossina sp.). [2]. 
Animal African trypanosomosis (AAT) or nagana disease is caused by T. congolense, T. vivax and T. brucei spp. In 
wild animals, these parasites cause relatively mild infections while in domestic animals they cause a severe, 
often fatal disease. Two tsetse-transmitted parasites, T. brucei gambiense and T. brucei rhodesiense, cause 
human African trypanosomiasis (HAT)/sleeping sickness, which affects both humans and animals. [5][11] 
Trypanosomes are protozoan parasites of the genus Trypanosoma (Figure 1), order Kinetoplastida. The present 
monograph will focus on AAT, and more specifically T. congolense and T. vivax, and, to a lesser extend T. brucei. 
Other important Trypanosoma, but not covered in the present study, can be seen in figure 1 below. 
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Figure 1: Trypansomatidae classification. Source: Dr Theo Baltz, University of Bordeaux 
 
Trypanosomes have as characteristic organelles, a kinetoplast and a flagellum (Figure 2). Typically, 
trypanosomes are digenetic parasites and thus require two hosts to complete their life cycle: they multiply in the 
blood, tissues or body fluids of a vertebrate host (Figure 3).  T. congolense resides in the subgenus Nannomonas, 
a group of small trypanosomes with medium-sized marginal kinetoplasts, no free flagella, and poorly developed 
undulating membranes (Figure 2). In East Africa, T. congolense is considered to be the single most important 
cause of AAT. This trypanosome is also a major cause of the disease in cattle in West Africa. [2][11] 
 T. vivax is a member of the subgenus Duttonella, a group of trypanosomes with large terminal kinetoplasts, 
distinct free flagella, and inconspicuous undulating membranes. T. vivax is a large (18-26 μm long) monomorphic 
organism that is very active in wet-mount blood smears. Although this organism is considered to be less 
pathogenic for cattle than T. congolense, it is nevertheless the most important cause of AAT in West African 
cattle. This trypanosome readily persists in areas free of tsetse flies (for example, in Central and South America 
and in the Caribbean), where it is transmitted mechanically by biting flies or contaminated needles, syringes, and 
surgical instruments [2][20]. 
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Figure 3: Life cycle of Trypanosomas Source: Adama Sow, 2013 
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Susceptible animal species  
• Cattle, sheep, goats, pigs, horses, camels, dogs, cats, and monkeys are susceptible to AAT and may suffer 
syndromes ranging from subclinical mild or chronic infection to acute fatal disease. Rats, mice, guinea 
pigs, and rabbits are useful laboratory species.  
• Table 1 below summarises the susceptibility of different domestic mammals and human to different 
major Trypanosomas. 
• More than 30 species of wild animals can be infected with pathogenic trypanosomes, and many of these 
remain carriers of the organisms. Ruminants are widely known to be active reservoirs of the 
trypanosomes. Wild equidae, lions, leopards, and wild pigs are all susceptible and can also serve as 
carriers of trypanosomes. 
• T. vivax DNA has been found by PCR in crocodiles and monitor lizards in Africa, but whether this 
organism can become established in reptiles or it is merely inoculated transiently by insect remains to 
be determined. Experimental infections can be established in laboratory animals including mice, rats, 
guinea pigs and rabbits [13]. 
• Certain cattle breed, especially the N’Dama, a Bos taurus-type from West Africa, are known to be 
trypanotolerant, having the ability to survive, reproduce and remain productive under trypanosomosis 
risk without the aid of trypanocidal drugs [4]. 
 
Table 1: Susceptibility of various animal species and humans to different Trypanosomes (Source: adapted 
by Theo Baltz, University of Bordeaux) 
 







+++  (70% of 
the problem) 
++ + - X Blood (capillary 
mainly) 
T vivax  +++ ++ - ++ X  Blood and CNS   
T evansi ++ + ++ +++/++ 
(Surra) 
X  
T brucei brucei + ++ + +++/++ X Tissues, blood (low 
level) and CNS 
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T brucei gambiense + ++ + +++/++ +++ (West A – 
more chronic) 
 







Trypanosomes can be found wherever the tsetse fly vector exists. Tsetse flies are endemic in Africa between 
latitude 15° N and 29° S, from the southern edge of the Sahara desert to Zimbabwe, Angola and Mozambique. 
Trypanosomes, particularly T. vivax, can spread beyond the “tsetse fly belt” by transmission through mechanical 




Figure 4: distribution of Tsetse and cattle in Africa (Source PATTEC) 
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Vectors and Transmission 
 In Africa, the primary vector for T. congolense, T. vivax, and T. b. brucei is the tsetse fly. These trypanosomes 
replicate in the tsetse fly and are transmitted through tsetse fly saliva when the fly feeds on an animal. Although 
there are up to 23 species of Glossina in sub-Saharan Africa between latitudes 14°N and 29°S that are 
competent, the three main species of tsetse flies for transmission of trypanosomes are: 
• Glossina morsitans, which favors the open woodland of the savanna;  
• G. palpalis, which prefers the shaded habitat immediately adjacent to rivers and lakes; and  
• G. fusca, which favors the high, dense forest areas. [20] 
These tsetse flies remain infected by trypanosomes for life. Trypanosome life cycle involves cyclical development 
in the tsetse fly, taking up to 3 or more weeks depending on trypanosome species and ambient temperature 
[2][11]  
Trypanosomosis is also mechanically transmitted by tsetse and other biting flies through the transfer of blood 
from one animal to another. The most important mechanical vectors are flies of the genus Tabanus, but 
Haematopota, Liperosia, Stomoxys, and Chrysops flies have also been implicated. Mechanical transmission can 
occur when interrupted feeding is re-started on a new host; thus it is efficient inside a group of animals but has 
little chance to occur at distance. In Africa, both T. vivax and T. b. brucei have spread beyond the "tsetse fly 
belts" [3], where transmission is principally by tabanid and hippoboscid flies. 
The vector for T. vivax in the Western Hemisphere remains unknown, but several species of hematophagous 




Figure 5:  Glossina morsitans morsitans (source Ray Wilson)  
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The course of disease due to infection with trypanosomes is variable and there are no clinical signs specific to 
bovine trypanosomosis. The manifestations of disease depend upon the degree of damage to specific organs 
and upon the degree of anaemia. Trypanosomosis in cattle may be acute, subacute or chronic [2]. Furthermore, 
because simultaneous infections with more than one trypanosome species are very common in most regions, [2], 
and simultaneous infection with trypanosomes and other hemoparasites (Babesia spp., Theileria spp., 
Anaplasma spp., and Ehrlichia spp.) frequently occurs, it is difficult to conclude which clinical signs are 
attributable to a given parasite.  
The cardinal clinical sign observed in AAT is anemia, which occurs within a week of infection with T. congolense 
and T. vivax. There is usually a pronounced decrease in packed cell volume, hemoglobin, red blood cell, and 
white blood cell levels, and within 2 months these may drop to below 50 percent of their pre-infection values. 
Also invariably present are intermittent fever, edema and loss of condition. Abortion may be seen, and infertility 
of males and females may be a sequel. Most cases of trypanosomiasis are chronic, but acute disease, which may 
be fatal within a week, can also occur. 
The severity of the clinical response is dependent on the species and the breed of affected animal and the dose 
and virulence of the infecting trypanosome. Stress, such as poor nutrition or concurrent disease, plays a 
prominent role in the disease process [2][5][11].  
T. congolense is a hematic trypanosome found only in the blood vessels of the animals it infects. It does not 
localize and multiply outside blood vessels. Infection with T. congolense may result in peracute, acute, or chronic 
disease in cattle, sheep, goats, horses, and camels. The incubation period is followed by intermittent febrile 
episodes, depression, lethargy, weakness, loss of condition, anemia, salivation, lacrimation, and nasal discharge. 
As the disease progresses, loss of condition and hair color changes from black to metallic brown are seen. The 
back is often arched and the abdomen "tucked up." Anemia is a prominent sign. Early in the infection, the 
organisms are readily demonstrable in blood smears, but, as the disease progresses to its acute and chronic 
forms, organisms are most readily demonstrated in lymph node smears. [2][5][11]. 
T. vivax has a variable incubation period, and, although it is considered to be less virulent for cattle than T. 
congolense, mortality rates of over 50 percent can occur. There seems to be a marked variation in the virulence 
of different strains of T. vivax, but it remains the most important cause of trypanosomosis of cattle, sheep, and 
goats in West Africa. T. vivax is often difficult to find in blood smears and can also be demonstrated in lymph 
node smears. 
The marked immunosuppression resulting from trypanosome infection lowers the host's resistance to other 
infections and causes in secondary disease, which greatly complicates both the clinical and pathological features 
of trypanosomiasis [2][8][16] 
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Incubation period is generally 8-20 days. T. congolense usually becomes apparent in 4–24 days, while T. vivax in 
4–40 days, and T. brucei brucei appearance is highly variable [2][5]. 
 
Clinical Diagnosis 
Trypanosomiasis should be suspected when an animal in an endemic area is anemic and in poor condition. 
Confirmation depends on the demonstration of the organism in blood or lymph node smears. Poor nutrition, 
concurrent diseases, and other stressors often affect the course of AAT, which usually is chronic [2][5][11].  
 
Differential Diagnosis 
Acute trypanosomosis with fever should be differentiated with:  
• Babesiosis  
• Anaplasmosis  
• Theileriosis (East Coast Fever)  
• Haemorrhagic septicaemia  
• Anthrax  
Chronic trypanosomosis with anaemia and emaciation:  
• Helminthosis  
• Malnutrition  
• Other haemoparasitoses [11] 
 
Laboratory diagnosis 
In the early phases of infection, especially with T. vivax and T. congolense, the parasite can readily be observed 
by microscopic examination of a wet-mount of blood slides. Thick blood films and stained with Giemsa are also a 
good technique (Figure 6). Diagnostic sensitivity is increased significantly by concentrating the parasites prior to 
examination in combination with a phase-contrast or dark-ground microscope. The centrifugation parasite 
concentration techniques have the added advantage that the packed cell volume, and hence the level of 
anaemia, can be determined at the individual animal and/or herd level [20] 
Serological methods include antigen and antibody ELISA, and the indirect fluorescent antibody (IFA) test [20] 
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Table 2: Number of AAT outbreaks reported to the OIE between 2005-2015 (Numbers given only for the 
target countries). Source: OIE.  
http://www.oie.int/wahis_2/public/wahid.php/Diseaseinformation/statusdetail 
 
Country 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 
West Africa 
Burkina Faso + + + + + + + 0 0 + + 
Ivory Coast 3 0 0 + + >3 >1 + + >5 + 
Mali + + ? - + - - - - - - 
Senegal 5 0 + 0 1 0 0 0 0 1 + 
East Africa 
Ethiopia + + >4 + + + + + + + + 
Kenya + >13 14 ? ? ? ? ? ? 9 0 
Rwanda - ? ? + + + + 9 16 - - 
Tanzania + >25 181 49 29 25 22 13 22 27 9 
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2- AU-IBAR:  The number of outbreaks reported to AU-IBAR is included in the Pan African Animal Resources Year 
Book. (http://www.au-ibar.org/pan-african-animal-resources-yearbook?showall=&limitstart=) and can be 
seen for the countries of interest in Table 3 below.   
Uganda + + + + + + + + + + - 
Southern Africa 
Madagascar 0 0 0 0 0 0 0 0 0 0 0 
Malawi + + 2 + 2 2 0 1 0 - - 
Mozambique 10 5 4 6 3 >4 ? 4 2 6 - 
South Africa 0 14 15 10 70 5? + 0 0 0 - 
Zambia - 34 28 61 116 87 + 33 61 83 - 
 
-   No information,      +   Present but quantitative data not known,   ?  Disease suspected 
Table 3: Number of AAT outbreaks reported to the AU-IBAR from 2005 to 2015 (numbers given only for the 
target countries). Source: AU-IBAR Year Books. 
 
Country 2005* 2006** 2007 2008 2009 2010 2011 2012 2013 2014 2015 
West Africa 
Burkina Faso            
Ivory Coast       4   5  
Mali            
Senegal     1       
East Africa 
Ethiopia   5 7 12 
cases 
1 2     




224 144 9 11  
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Year Area Species of 
animal 







363 followed over 2 
years 
Beginning of survey 7.5% 
based on PCV 
T. vivax 66.3% 
T. congolense 23.8% 
Guiguigbaza-
Kossigan Dayo et 




Rwanda            






21 10 17 17  
Uganda  8 1 9 11 30 130 10 2 1  
Southern Africa 
Madagascar            
Malawi  1 1   1  1    
Mozambique  5 6 10 3 6 3  1   
South Africa  14  10 6 7 5 9 6 7  
Zambia   28 2 18 16 39 16 66 62  
 
*AU-IBAR didn’t start yet producing data for AAT 
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Year Area Species of 
animal 
No. of samples 
tested 
% positive Reference 
2012 Amhara region, 
Northwest Ethiopia 






Cattle 424 15% Tekle, 2012  
 
Ivory Coast 
Year Area Species of 
animal 
No. of samples 
tested 
% positive Reference 
2012 Northern Livestock 
Area 
 363 overall prevalence of 
22.31% (PCR) 
 




Year Area Species of 
animal 
No. of samples 
tested 
% positive Reference 
2010 Suba and Teso 
districts in Western  






No prevalence study data could be found 
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Year Area Species of animal No. of samples 
tested 
% positive Reference 
2009 Kadiolo Circle Zebu, N’Dama and 
Zebu N’Dama cross 
473 30.8% overall; 89%Tc, 
9.5% Tv  
Bocoum Z et al., 
2012  
2014 cercles de 
Kadiolo et 
Sikasso 
 1208 1.2% Bass et al ; 2014  
 
Mozambique 
Year Area Species of 
animal 
No. of samples 
tested 
% positive Reference 
2002* Central cattle 16895  Specht, 2008  
 
*In smallholder cattle T. congolense was the predominant species at 41.53 %, followed by T. vivax at 31.84 % 
and T. brucei at 18.16 %; Infections with T. vivax + T. congolense accounted for 2.98 %, T. vivax + T. brucei for 
2.32 %, T. congolense + T. brucei for 2.98 % and, with all three species, for 0.19 % of the infections. In 
commercial cattle T. vivax was the predominant species at 42.25 %, followed by T. congolense at 37.45 % and T. 
brucei at 15.68 %. Mixed infections accounted for 4.61 % of all infections. 
 
Rwanda 
No recent data could be found 
 
Senegal 
Year Area Species of 
animal 
No. of samples 
tested 
% positive Reference 
2010 Western Senegal cattle 1332 Overall 2.4% Seck et al., 2010  
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Year Area Species of 
animal 
No. of samples 
tested 
% positive Reference 








Year Area Species of 
animal 
No. of samples 
tested 
% positive Reference 
2014 Mulanda, Tororo 
District 
Zebu cattle 300 5% Nabulime et al, 
2014  




Year Area Species of 
animal 
No. of samples 
tested 
% positive Reference 
1988 South-West Cattle 3,346 10.22% Corten et al, 1988  
2008-
2010 




al., 2015  
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Economic and Social Impacts at Global 







In sub-Saharan Africa (SSA), -AAT- is one of the most important animal diseases - with more than 80 million 
cattle exposed to infective tsetse fly bites (T. congolense, T. brucei brucei) or infective tsetse fly and biting fly 
bites (T. vivax) [9]. It is estimated to cause annual losses that run into billions of dollars. AAT currently causes 
direct annual losses of some US$ 1.5 billion and, overall, has the effect of limiting Africa’s agricultural income to 
some US$ 4.5 billion a year below its potential level [5]. 
African animal trypanosomiasis is indeed considered one of the root causes of hunger and poverty in most SSA 
countries where it represents a serious impediment to sustainable agricultural rural development. About 80% of 
land in SSA is tilled by hand due to the high risk of AAT that threatens the survival and use of draught animals. 
Trypanosomiasis is generally recognised as a very serious disease which may be fatal if left untreated. This is 
particularly true in susceptible animals, such as zebu cattle [10], but also trypano-tolerant animals, like N’Dama 
cattle, which may suffer from the pathological stress caused by trypanosomiasis, as assessed by anaemia 
development and reduced growth [1][10][18]. The FAO estimates that every year more than three million cattle die 
of trypanosomiasis [6]; in addition there are significant indirect losses to the livestock sector due to abortion, 
infertility, weight losses, reduced draught power, reduced milk production [12], all of which impact people’s 
livelihoods and animal welfare. The fight against the disease is either managed by the control of the vector or of 
the parasite or a combination of both [12]. However, in poor rural communities, which are mostly affected by the 
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Methods for the control of the trypanosomiases has changed little in the last hundred years and still rely on four 
pillars of basic management: (i)the control of the vector, (ii) the correct diagnosis of the disease, (iii) the use of 
trypanocidal and prophylactic drugs and (iv) the use of trypanotolerant livestock. There is still no vaccine or 
immunisation method to date for AAT [5]. Integrated strategies, combining these different elements, but 
associated with very good animal husbandry are critical for successful and sustainable control and should be 
encouraged and implemented [23].  
 
Vector control 
Several approaches to fly control and eradication have been used with varying degrees of success. 
Game elimination: this method which consisted in large-scale hunting of wild hosts of tsetse took place in 
Zimbabwe between 1930s and 1960, when it was abandoned [2]  
The next methods focused on the fly.  
Bush clearing: this consisted in the application of residual insecticides to tsetse resting sites by ground-based 
spraying teams. Extensively used in early tsetse fly eradication campaigns, has been locally useful because it 
eliminates the breeding places of the tsetse. But, to be completely effective, bush clearing requires ecologically 
unacceptable destruction of vast areas of brush and forest. It is still a useful procedure when used locally in 
conjunction with other control methods. 
Since the relative success of these different approaches, which worked when accompanied by strict support 
systems, more other approaches have been employed in different regions and different times. These have 
included Trapping, aerial and ground spraying of insecticides, the use of dips or the application of pour-on 
formulations of insecticides to animals and the use of sterile male techniques, generally known as Sterile Insect 
technique or SIT. 
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Ground and aerial spraying with insecticides and the use of synthetic pyrethroids on cattle have lowered fly 
densities in some areas, but widespread use would require considerable international cooperation and expense. 
Widespread application of insecticide has the tremendous disadvantage of also eradicating many other 
arthropods, several of which are desirable. The recent introduction of odour-baited targets impregnated with 
insecticides is proving promising as a means of reducing the tsetse fly [7]. 
SIT: Inspired from the success of the sterile male technique on screwworm eradication in the United States, the 
SIT has been a big focus since the 1980s for Tsetse and Trypanosoma control and eradication. SIT is a genetic 
population suppression approach and involves sustained, systematic releases of irradiated sterile male insects 
among the wild population. The insects to be released are mass reared in large-scale insectaries. Males are 
sterilized by irradiation and then taken to the selected area and released by air.  Early problems with breeding of 
the male flies have been overcome, and field trials have been done in both east and west Africa to determine 
the effectiveness of this approach in vector control. In limited trials, such as in the Unguja Island of Zanzibar, 




The use of trypanocidal drugs is currently the main method for controlling trypanosomiasis in all the countries 
where this disease occurs. Three compounds belonging to two chemical classes are widely available to treat 
trypanosomosis: diminazene diaceturate (belonging to the class of aromatic diamidines); and, isometamidium 
chloride hydrochloride and homidium (chloride and bromide salts) which belong to the phenanthridinium class 
of trypanocidal agents [14] 
It is estimated that every year 25 to 30 million doses of curative and prophylactic anti trypanosomiasis drugs are 
administrated in Africa [14]. Ideally, their application should be under the control of qualified veterinary 
authorities but in fact this is rarely the case and most trypanocidal drugs are used directly by the livestock 
owners themselves, usually in the absence of definitive diagnosis of the disease. This situation has certainly 
promoted the invasion of the market with fake, non-effective trypanocidal drugs [17]. In addition there is 
evidence for the appearance of trypanosome strains that are resistant to these drugs. 
 
Trypanotolerance 
It has long been recognized that certain breeds of African cattle are considerably more resistant to African 
trypanosomiasis that others. This is especially true of the West African short-horned cattle (Muturu, Baoule, 
Laguna, Samba, and Dahomey) and the N'Dama, which is also of West Africa.  Susceptibility studies have shown 
the N'Dama to be the most resistant breed followed by the smaller West African short-horned cattle, but the 
large and more recently introduced Zebu is the most susceptible [5][10]. Studies have revealed that a key element 
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of the resistance of this breed to trypanosome infection is its high ability to control the level of the parasitaemia 





Figure 7: Evaluation of parasitemia and haematocrit between treapanotolerant cattle (NDama) and 
susceptible cattle (Boran); Source: adapted by Prof. T Baltz from Authié et al. [21] 
 
Disease situation and government policies by country 
Trypanosomosis is not a notifiable disease, and there is no vaccine, so it was not included in the questionnaires 
sent to the veterinary services of the countries of interest.  
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However, there are countries where control campaigns have been implemented, for example in Uganda, where 
the SOS Uganda program. 
The Stamp Out Sleeping sickness (SOS) campaign is a public private partnership launched in Kampala, Uganda in 
October 2006. This partnership was formed in response to an emergency situation arising in a number of 
districts in Northern Uganda where the two strains of Human African Trypanosomiasis (HAT) – also known as 
“sleeping sickness”- threaten to converge. This could have a catastrophic effect for the already stretched local 
health services. Sleeping sickness threatens more than 66 million people in sub-Saharan Africa, whereof ten 
million in Uganda, killing more than 100 people a day. 
For more details: http://www.stampoutsleepingsickness.com/about-sos-.aspx  
http://www.ceva-africa.com/en/Responsibility/Program-supports/SOS-Uganda   
 
AU-PATTEC, the African Union - Pan African Tsetse and Trypanosomiasis Eradication Campaign, was established 
following the adoption of Decision AHG/Dec. 156 (XXXVI) by the African Heads of States and Government during 
the OAU Summit held in Lome, Togo in July 2000, urging Member States to embark on a Pan African Tsetse and 
Trypanosomiasis Eradication Campaign. The PATTEC Coordination office was established in 2002 and was 
assigned the task of helping to initiate and coordinate the activities of the tsetse and Trypanosomiasis 
eradication campaign, within the framework of implementing the decision of the African Heads of State and 
Governments.  The roles of PATTEC are: 
• Identification of Target Areas 
• Selection and Prioritization of Intervention Areas 
• Project Initiation 
• Project Support 
• Harmonization of Different Programs 
• Project Monitoring and Evaluation  
The current PATTEC coordinator Dr Hassane H. Mahamat, has reactivated the organisation and taken a very 
proactive attitude. There are frequent meetings and activities, where the countries can provide updates on 
progress, and regional activities (for example the Congo Basin or Sudan) can be promoted.  
For more details:  http://pattec.au.int/home  
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There is no vaccine available. 
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Although no vaccine is available to date, table 4 provides TPP that were developed in the context of GALVmed 
Trypanososmosis vaccine. This TPP was reviewed by panels of disease experts and has been published in 
GALVmed website: http://www.galvmed.org/en/news/trypanosomosis/  
 
Table 4: Target Product Profile (TPP) Trypanosomosis vaccine – Proposal: 
 
Attribute Minimum  Ideal  
1. Antigen Immunogen with T. congolense 
&/or T. vivax antigens. 
Immunogen with T. congolense & T. vivax 
antigens. 
2. Indication for use For active immunisation of cattle 
against T. congolense &/or T. 
vivax. 
For active immunisation of cattle, sheep,  
goats & camels against T. congolense & 
T.vivax. 
3. Target species Cattle. Cattle, sheep, goats, equines & camels. 
4. Recommended Dose <5 ml (cattle). Same dose for cattle and sheep: 2ml. 
5. Pharmaceutical form Reconstituted injectable solution/ 
suspension. 
Ready to use solution/ suspension. 
6. Route of administration  
 
Subcutaneous or intramuscular. Subcutaneous and intramuscular. 
7. Regimen - primary vaccination 
course 
Maximum of two doses given 2- 6 
weeks apart. 
Single dose. 
8. Regimen - booster 6 monthly booster. Annual dose. 
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9. Epidemiological relevance Protection against T. congolense 
&/or T. vivax in affected regions. 
Protection against T. congolense & T. vivax 
in affected regions. 
10. Recommended age at first 
vaccination  
 
When other vaccines are applied 
(normally 3-4 months of age). 
From 1-2 months of age (as early as 
possible). 
 
11. Onset of immunity  2-3 weeks following primary 
vaccination. 
One week following primary vaccination. 
12. Duration of immunity  Six months following first booster 
vaccination. 
Life time immunity. 
13. Expected efficacy  
 
To prevent disease in > 70% of 
vaccinated animals   
[For registration studies: 
prevention of clinical disease (no 
proportional decrease in PCV 
greater than 20%*).] 
 
To prevent infection and transmission in 
100% of the animals. 
[For registration studies: absence of 
parasitaemia and clinical signs,  and 
sustained normal haematocrit]. 
14. Expected safety  Mild and transient injection site 
reactions and pyrexia lasting less 
than 14 days. Transient milk 
reduction 
No injection site reactions and no pyrexia 
nor milk reduction. 
15. Withdrawal period  
 
1-2 weeks at point of injection for 
meat. 
Nil for milk and meat. 
 
16. Special requirements for 
animals  
Vaccinate only clinically healthy 
animals. 
Vaccinate all animals. 
17. Special requirements for 
persons  
No severe reaction after 
accidental self-injection. 
No reaction on self-injection. 
18. Package size  10 and/or 50 doses. <10, 50, 50, 100, 250 doses. 
19. Price to end user <$5/dose $1-2.00/dose to end user. 
20. Storage requirements Stable at 2-8°C for 24 months. Stable at 30°C for 24 months. 
21. Shelf-life as packaged for sale  18 months. 36 months. 
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22. Shelf-life after first opening 
(in-use stability) 
1 hour. 24 hours or greater. 
23. In-use preservative for 
inactivated vaccines  
Any approved preservative. 
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ANNEX 1:  Additional data on disease presence and 
incidence 
 




When different animal health statuses between domestic and wild animal population are provided, the box is split in two: 
the upper part for domestic animals, and the lower part for wild animals.  
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Trypanosomosis in Western Africa: Burkina Faso, Ivory Coast, Mali and Senegal 
 
Trypanosomosis in Southern Africa: Madagascar, Malawi, Mozambique, South Africa and Zambia 
 
 
